课题基金 / 基金详情

Identification and clinical application for the role of NKT cells in patients with chronic hepatitis and hepatocellualr carcinoma infected hepatitis virus

Identification and clinical application for the role of NKT cells in patients with chronic hepatitis and hepatocellualr carcinoma infected hepatitis virus
NKT细胞在肝炎病毒感染的慢性肝炎及肝癌患者中的作用鉴定及临床应用
批准号:
15390236
负责人:
KAKUMU Shinichi
金额:
$9.09万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

KAKUMU Shinichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural killer T (NKT) cells share features of both classical T cells and NK cells. NKT cells are heterogenous populations, and recognize glycolipids associated with CD1d molecule. We investigated Th1/Th2 cytokine production as well as frequency and phenotype of circulating NKT cells in patients with chronic hepatitis (CH) and hepatocellular carcinoma (HCC) infected with hepatitis C virus (HCV). Peripheral blood mononuclear cells (PBMC) were obtained befor and 2 weeks later IFN/ribavirin and radiofrequency ablation therapy for CH and HCC, respectively. PBMC were cultured with α galactosylceramide (α GalCer) and IL-2. Frequency and cytokine production of NKT cells were analyzed with flow cytometry. IFN-γ production of Vα 24+CD3+ T cells did not differ among groups, but became greater after treatment in contrast to lowered IL-4 production.The function of dendritic cells (DCs) appears to be decreased in patients with chronic hepatitis C. However, we have no strategy to modulate its functi … More on. Thus we wanted to induce maturated DC by activating V α 24+ NKT cells. We cultured peripheral blood CD14+ cells in the presence of GMCSF and IL-4. Simultaneously CD3+ T cells were cultured with α GalCer + IL-2. After 5-day culture, they are mixed and cultured with GMCSF, α GalCer and IL-2 for further 2 days. This method induced matured, functional DC.Cytotoxic T lymphocyes (CTLs) are thought to be major effectors for clearing viruses in acute infections including hepatitis B virus (HBV). Persistent HBV infection is characterized by a lack of or a weak CTL response to HBV, which is thought to reflect tolerance to HBV antigens. We found that α GalCer, a ligand for V α 14+ NKT cells in mice, strongly enhanced the induction and proliferation of HBV-specific CTLs by HBsAg. In HbsAg transgenic mice, which are thought to be tolerant to HBV-encoded antigens, administration of HbsAg or α GalCer alone failed to HbsAg-specific CTLs, but they were induced by administration of both compounds. A blocking experiment using antibodies to cytokines and CD4O ligand showed that IL-2 mediates the enhancement of CTL induction caused by α GalCer through NKT activation. Less
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
The efficacy and safety of thymosin α1 in Japanese patients with chronic hepatitis B ; results of a randomized clinical trial.
胸腺肽α1对日本慢性乙型肝炎患者的疗效和安全性;一项随机临床试验的结果。
DOI: --
发表时间: 2005
期刊: J Viral Hepatitis 12
影响因子: --
作者: [Iino S, Toyota J, Kumada H, et al.]
通讯作者: et al.
Kasahara S, et al.: "Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes"J Virol. 77. 2469-2477 (2003)
Kasahara S 等人:“缺乏肿瘤坏死因子 α 会导致乙型肝炎病毒特异性细胞毒性 T 淋巴细胞增殖受损”J Virol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Continued ribavirin monotherapy following interferon-ribavirin combination therapy is not effective for chronic hepatitis C.
干扰素-利巴韦林联合治疗后继续利巴韦林单药治疗对慢性丙型肝炎无效。
DOI: --
发表时间: 2006
期刊: Hepatol Res 32
影响因子: --
作者: [Dohmen K, Mizuta T, Ishibashi H, et al., Kakumu S.]
通讯作者: Kakumu S.
Changes in natural killer T cell subsets during therapy in type C hepatitis and hepatocellular crcinoma.
丙型肝炎和肝细胞癌治疗期间自然杀伤 T 细胞亚群的变化。
DOI: --
发表时间: 2005
期刊: Hepatol Res 32
影响因子: --
作者: [Okumura A, Ishikawa T, Maeno T, et al.]
通讯作者: et al.
9
    To clarify the mechanism of chronicity and to explore therapeutic approach for viral hepatitis
    • 批准号:
      12670529
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      KAKUMU Shinichi
    • 依托单位:
    Pathologicl significance and its inhibition of apoptosis on the development and its progression of liver injury.
    • 批准号:
      10470142
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.45万
    • 财政年份:
      1998
    • 负责人:
      KAKUMU Shinichi
    • 依托单位:
    IMMUNO-PATHOGENESIS AND-THERAPY OF VIRAL HEPATITIS
    • 批准号:
      09044341
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $2.24万
    • 财政年份:
      1997
    • 负责人:
      KAKUMU Shinichi
    • 依托单位:
    Cellular immune response against HBV nucleocapsid antigen
    海外基金